Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN Y7017 in Mild to Moderate Alzheimer's Dementia
jRCT2080220079Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Memantine with Placebo (2 arms).
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT2080220079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220079.